NCT07750184 Immediate Effects of Kinesio Taping on Thoracic Outlet Syndrome
| NCT ID | NCT07750184 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Thoracic Outlet Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2026-09-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the immediate effects of Kinesio Taping compared with sham taping in adults with Thoracic Outlet Syndrome (TOS). The study aims to determine whether a single application of Kinesio Taping provides greater improvements in symptom severity, grip strength, and hand dexterity than sham taping. The main questions it aims to answer are: Does a single application of Kinesio Taping reduce symptom severity and improve tolerance to the Roos test compared with sham taping? Does a single application of Kinesio Taping improve grip strength and hand dexterity compared with sham taping? Researchers will compare participants receiving Kinesio Taping with those receiving sham taping to determine whether the observed effects are attributable to the therapeutic application of Kinesio Taping rather than nonspecific or placebo effects. Participants will: * undergo baseline assessments of symptom severity during the Roos test, Roos test completion time, grip strength, and hand dexterity; * be randomly assigned to receive either Kinesio Taping or sham taping; * undergo immediate post-intervention assessments using the same outcome measures.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of Thoracic Outlet Syndrome (TOS) confirmed by a thoracic surgeon. * Presence of symptoms consistent with TOS. * Ability to understand the study procedures and provide written informed consent. Exclusion Criteria: * History of fracture or surgery involving the cervical spine, shoulder, elbow, wrist, or hand that could affect upper-extremity function. * Neurological disorders affecting upper-extremity function (e.g., stroke, multiple sclerosis, peripheral neuropathy unrelated to TOS). * Other upper-extremity musculoskeletal disorders that may influence grip strength or hand dexterity (e.g., carpal tunnel syndrome, trigger finger, thumb carpometacarpal osteoarthritis). * Skin lesions, allergy to adhesive tape, or any dermatological condition preventing tape application. * Pregnancy. * Inability to perform the assessment procedures.
Contact & Investigator
FERAY KARADEMİR, PhD
PRINCIPAL INVESTIGATOR
Cumhuriyet University
Frequently Asked Questions
Who can join the NCT07750184 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Thoracic Outlet Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07750184 currently recruiting?
Yes, NCT07750184 is actively recruiting participants. Contact the research team at karademirferay@gmail.com for enrollment information.
Where is the NCT07750184 trial being conducted?
This trial is being conducted at Merkez, Turkey (Türkiye).
Who is sponsoring the NCT07750184 clinical trial?
NCT07750184 is sponsored by Hacettepe University. The principal investigator is FERAY KARADEMİR, PhD at Cumhuriyet University. The trial plans to enroll 32 participants.